SCHEMBL7846527

SCHEMBL7846527

CCCCC(CO)CCCCN(Cc1ccccc1)S(=O)(=O)c1ccc(N(C)C)cc1Cc1ccc(OC)cc1

nearest known ligand 0.46

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 3/20 0.46
L3MBTL1 Q9Y468 1/20 0.42
CNR1 P21554 1/20 0.42
TAS2R14 Q9NYV8 7/20 0.40
BMP1 P13497 1/20 0.40
PTGES O14684 1/20 0.39
TAS2R8 Q9NYW2 1/20 0.39
CXCR3 P49682 1/20 0.39
TDP1 Q9NUW8 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
PTPN1 P18031 1/20 0.37
KEAP1 Q14145 1/20 0.36
NFE2L2 Q16236 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7845258 0.87 L3MBTL1 (0.41) CNR2L3MBTL1CNR1TAS2R14BMP1
SCHEMBL7838193 0.85 ALDH1A1 (0.41) CNR2CNR1CXCR3TDP1KMT2A
SCHEMBL7846766 0.84 CNR2 (0.40) CNR2CNR1TAS2R14BMP1PTGES
SCHEMBL7846493 0.81 ALDH1A1 (0.38) CNR2MEN1KMT2A
SCHEMBL7846525 0.79 CNR2 (0.40) CNR2CNR1TAS2R14PTGESTAS2R8
SCHEMBL7846899 0.75 CNR2 (0.38) CNR2CNR1TAS2R14BMP1MEN1
SCHEMBL7846313 0.75 ALDH1A1 (0.39) CNR2CNR1CXCR3TDP1MEN1
SCHEMBL7848884 0.75 CNR2 (0.35) CNR2L3MBTL1BMP1
SCHEMBL7846110 0.75 CNR2 (0.37) CNR2CNR1TAS2R14BMP1MEN1
SCHEMBL7837398 0.74 ALDH1A1 (0.36) CXCR3TDP1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1155007-A2 1,2-BENZOTHIAZEPINES FOR THE TREATMENT OF HYPERLIPIDEMIC DISEASES G.D. Searle LLC (US) 2001-11-21 EP disclosed
WO-2000047568-A2 1,2-BENZOTHIAZEPINES FOR THE TREATMENT OF HYPERLIPIDEMIC DISEASES G.D. SEARLE LLC (US) 2000-08-17 WO disclosed